Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Molecular Dynamics Simulation | 17 | 2021 | 4155 | 2.03 | Why? |
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 2 | 2017 | 2 | 1.42 | Why? |
| Cyclic AMP | 2 | 2017 | 76 | 1.34 | Why? |
| Thermodynamics | 7 | 2021 | 873 | 1.06 | Why? |
| Cytidine Deaminase | 3 | 2018 | 109 | 0.93 | Why? |
| Imidazolines | 1 | 2019 | 1 | 0.84 | Why? |
| Benzyl Compounds | 1 | 2019 | 13 | 0.83 | Why? |
| Tumor Suppressor Protein p53 | 3 | 2018 | 310 | 0.80 | Why? |
| Nucleocytoplasmic Transport Proteins | 1 | 2019 | 73 | 0.79 | Why? |
| Pregnancy Proteins | 1 | 2019 | 43 | 0.79 | Why? |
| Software | 4 | 2020 | 2501 | 0.75 | Why? |
| Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2017 | 2 | 0.72 | Why? |
| Models, Chemical | 2 | 2019 | 332 | 0.72 | Why? |
| Transcriptional Activation | 1 | 2018 | 196 | 0.70 | Why? |
| Receptors, Cytoplasmic and Nuclear | 1 | 2017 | 67 | 0.70 | Why? |
| Oligonucleotides | 1 | 2018 | 137 | 0.69 | Why? |
| Aspartic Acid | 1 | 2017 | 76 | 0.67 | Why? |
| Drug Design | 3 | 2021 | 2627 | 0.67 | Why? |
| Physics | 1 | 2016 | 46 | 0.65 | Why? |
| Protein Multimerization | 3 | 2020 | 1336 | 0.65 | Why? |
| Models, Molecular | 6 | 2021 | 7616 | 0.62 | Why? |
| Trypsin | 1 | 2017 | 209 | 0.62 | Why? |
| DNA | 2 | 2018 | 778 | 0.61 | Why? |
| Benzamidines | 1 | 2017 | 206 | 0.60 | Why? |
| Cryoelectron Microscopy | 2 | 2021 | 2372 | 0.57 | Why? |
| Arginine | 1 | 2017 | 377 | 0.54 | Why? |
| Polysaccharides | 1 | 2021 | 854 | 0.52 | Why? |
| Guanosine Monophosphate | 1 | 2012 | 11 | 0.51 | Why? |
| Nucleotidyltransferases | 1 | 2012 | 77 | 0.48 | Why? |
| Proteins | 2 | 2019 | 921 | 0.42 | Why? |
| Magnesium | 1 | 2012 | 290 | 0.41 | Why? |
| Catalytic Domain | 6 | 2021 | 1757 | 0.38 | Why? |
| Databases, Protein | 3 | 2017 | 523 | 0.38 | Why? |
| Ligands | 3 | 2019 | 1300 | 0.38 | Why? |
| Protein-Arginine N-Methyltransferases | 2 | 2017 | 12 | 0.36 | Why? |
| Binding Sites | 6 | 2021 | 6201 | 0.33 | Why? |
| Enzyme Activation | 2 | 2017 | 425 | 0.30 | Why? |
| Allosteric Regulation | 2 | 2017 | 134 | 0.29 | Why? |
| Protein Binding | 9 | 2021 | 11430 | 0.29 | Why? |
| Information Dissemination | 1 | 2020 | 2986 | 0.27 | Why? |
| Kinetics | 3 | 2017 | 3238 | 0.25 | Why? |
| Amino Acid Substitution | 2 | 2021 | 1706 | 0.24 | Why? |
| Protein Conformation, alpha-Helical | 3 | 2021 | 530 | 0.23 | Why? |
| Substrate Specificity | 3 | 2018 | 639 | 0.23 | Why? |
| Escherichia coli | 3 | 2018 | 1547 | 0.22 | Why? |
| Alprenolol | 1 | 2019 | 1 | 0.21 | Why? |
| Receptors, Nicotinic | 1 | 2021 | 81 | 0.21 | Why? |
| Adrenergic beta-2 Receptor Antagonists | 1 | 2019 | 16 | 0.20 | Why? |
| Receptors, Adrenergic, beta-2 | 1 | 2019 | 32 | 0.20 | Why? |
| Molecular Docking Simulation | 5 | 2021 | 6902 | 0.20 | Why? |
| Protein Conformation | 4 | 2018 | 4386 | 0.20 | Why? |
| Aminohydrolases | 1 | 2018 | 8 | 0.20 | Why? |
| Chemistry | 1 | 2018 | 14 | 0.19 | Why? |
| Uridine Diphosphate | 1 | 2018 | 1 | 0.19 | Why? |
| Response Elements | 1 | 2018 | 54 | 0.19 | Why? |
| Coenzymes | 1 | 2018 | 19 | 0.19 | Why? |
| Principal Component Analysis | 2 | 2020 | 689 | 0.19 | Why? |
| Glycolipids | 1 | 2018 | 19 | 0.18 | Why? |
| Lipid A | 1 | 2018 | 32 | 0.18 | Why? |
| Amino Acid Motifs | 2 | 2017 | 620 | 0.18 | Why? |
| Pyrophosphatases | 1 | 2018 | 39 | 0.18 | Why? |
| Recombinant Proteins | 3 | 2017 | 3786 | 0.18 | Why? |
| Holoenzymes | 1 | 2017 | 42 | 0.18 | Why? |
| Transcription Factor RelA | 1 | 2018 | 122 | 0.18 | Why? |
| Enzyme Stability | 1 | 2017 | 72 | 0.18 | Why? |
| Minor Histocompatibility Antigens | 1 | 2017 | 56 | 0.17 | Why? |
| Salts | 1 | 2017 | 44 | 0.17 | Why? |
| Computer-Aided Design | 1 | 2017 | 94 | 0.17 | Why? |
| Markov Chains | 1 | 2019 | 502 | 0.17 | Why? |
| Suppressor of Cytokine Signaling Proteins | 1 | 2016 | 13 | 0.17 | Why? |
| Biophysics | 1 | 2016 | 30 | 0.17 | Why? |
| Signal Transduction | 1 | 2014 | 7207 | 0.16 | Why? |
| Enzyme Inhibitors | 2 | 2017 | 1881 | 0.16 | Why? |
| Cloning, Molecular | 2 | 2017 | 1036 | 0.16 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.16 | Why? |
| Computer Graphics | 1 | 2017 | 124 | 0.16 | Why? |
| Crystallography, X-Ray | 3 | 2018 | 2689 | 0.16 | Why? |
| Carcinoma, Pancreatic Ductal | 1 | 2017 | 112 | 0.16 | Why? |
| Protein Interaction Domains and Motifs | 3 | 2021 | 2134 | 0.16 | Why? |
| Glycine | 1 | 2017 | 203 | 0.15 | Why? |
| Allosteric Site | 1 | 2017 | 211 | 0.15 | Why? |
| Computers | 1 | 2016 | 199 | 0.14 | Why? |
| DNA-Binding Proteins | 1 | 2018 | 469 | 0.14 | Why? |
| Nucleic Acid Conformation | 1 | 2018 | 621 | 0.14 | Why? |
| Static Electricity | 1 | 2017 | 397 | 0.14 | Why? |
| Conserved Sequence | 1 | 2017 | 751 | 0.14 | Why? |
| Inhibitory Concentration 50 | 1 | 2017 | 907 | 0.14 | Why? |
| Point Mutation | 1 | 2017 | 481 | 0.14 | Why? |
| Ubiquitin | 1 | 2016 | 243 | 0.14 | Why? |
| Creatine Kinase | 1 | 2016 | 386 | 0.13 | Why? |
| Computational Biology | 2 | 2020 | 4514 | 0.13 | Why? |
| Sequence Alignment | 2 | 2017 | 2109 | 0.13 | Why? |
| Gene Expression | 3 | 2021 | 3332 | 0.12 | Why? |
| Protein Structure, Secondary | 1 | 2017 | 1077 | 0.12 | Why? |
| Cattle | 1 | 2017 | 1336 | 0.12 | Why? |
| Lysine | 1 | 2012 | 153 | 0.12 | Why? |
| Mutation | 5 | 2021 | 12376 | 0.12 | Why? |
| Virion | 1 | 2020 | 1444 | 0.12 | Why? |
| Movement | 1 | 2014 | 232 | 0.12 | Why? |
| Amino Acid Sequence | 3 | 2018 | 6049 | 0.11 | Why? |
| RNA | 1 | 2018 | 1278 | 0.11 | Why? |
| NF-kappa B | 1 | 2018 | 1301 | 0.11 | Why? |
| RNA Caps | 1 | 2012 | 204 | 0.10 | Why? |
| History, 20th Century | 1 | 2016 | 1282 | 0.10 | Why? |
| Pancreatic Neoplasms | 1 | 2017 | 609 | 0.10 | Why? |
| Small Molecule Libraries | 1 | 2017 | 1060 | 0.09 | Why? |
| Computer Simulation | 2 | 2021 | 4982 | 0.09 | Why? |
| Quantum Theory | 2 | 2019 | 169 | 0.09 | Why? |
| Protein Conformation, beta-Strand | 2 | 2021 | 414 | 0.09 | Why? |
| Humans | 22 | 2021 | 930598 | 0.09 | Why? |
| Workflow | 1 | 2017 | 2373 | 0.08 | Why? |
| Drug Discovery | 1 | 2021 | 3092 | 0.08 | Why? |
| Cell Nucleus | 2 | 2018 | 399 | 0.08 | Why? |
| Cell Line, Tumor | 3 | 2018 | 3608 | 0.07 | Why? |
| Artificial Intelligence | 1 | 2020 | 3543 | 0.07 | Why? |
| HIV-1 | 1 | 2018 | 3365 | 0.06 | Why? |
| Colorectal Neoplasms | 1 | 2017 | 1884 | 0.06 | Why? |
| Machine Learning | 1 | 2019 | 4395 | 0.06 | Why? |
| Algorithms | 1 | 2020 | 7346 | 0.06 | Why? |
| Models, Biological | 1 | 2020 | 4907 | 0.06 | Why? |
| Drug Repositioning | 1 | 2021 | 5683 | 0.06 | Why? |
| Internet | 1 | 2017 | 6204 | 0.05 | Why? |
| Research Personnel | 2 | 2019 | 1037 | 0.05 | Why? |
| Women's Rights | 1 | 2019 | 61 | 0.05 | Why? |
| Active Transport, Cell Nucleus | 1 | 2018 | 203 | 0.05 | Why? |
| Streptavidin | 1 | 2017 | 27 | 0.04 | Why? |
| Hydrocarbons, Aromatic | 1 | 2017 | 10 | 0.04 | Why? |
| Cell Line | 3 | 2018 | 12040 | 0.04 | Why? |
| Ribosomal Proteins | 1 | 2018 | 94 | 0.04 | Why? |
| HCT116 Cells | 1 | 2017 | 83 | 0.04 | Why? |
| HT29 Cells | 1 | 2017 | 108 | 0.04 | Why? |
| Amines | 1 | 2017 | 67 | 0.04 | Why? |
| Mice, Inbred NOD | 1 | 2017 | 134 | 0.04 | Why? |
| S-Adenosylmethionine | 1 | 2017 | 137 | 0.04 | Why? |
| Drug Screening Assays, Antitumor | 1 | 2017 | 138 | 0.04 | Why? |
| Mice | 1 | 2017 | 21357 | 0.04 | Why? |
| DNA, Single-Stranded | 1 | 2017 | 95 | 0.04 | Why? |
| Cytoplasm | 1 | 2018 | 304 | 0.04 | Why? |
| Mice, SCID | 1 | 2017 | 225 | 0.04 | Why? |
| Immune Sera | 1 | 2021 | 884 | 0.04 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2017 | 274 | 0.04 | Why? |
| Scattering, Small Angle | 1 | 2016 | 91 | 0.04 | Why? |
| Glycosylation | 1 | 2021 | 1255 | 0.04 | Why? |
| Carcinogenesis | 1 | 2018 | 236 | 0.04 | Why? |
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 382 | 0.04 | Why? |
| Animals | 4 | 2021 | 78931 | 0.04 | Why? |
| X-Ray Diffraction | 1 | 2016 | 249 | 0.04 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.04 | Why? |
| Blotting, Western | 1 | 2017 | 863 | 0.04 | Why? |
| Ubiquitination | 1 | 2016 | 343 | 0.04 | Why? |
| HeLa Cells | 1 | 2018 | 1303 | 0.04 | Why? |
| Polymers | 1 | 2019 | 507 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Promoter Regions, Genetic | 1 | 2018 | 823 | 0.03 | Why? |
| Peptide Hydrolases | 1 | 2021 | 1269 | 0.03 | Why? |
| Career Choice | 1 | 2018 | 498 | 0.03 | Why? |
| Nanotechnology | 1 | 2019 | 821 | 0.03 | Why? |
| Viral Proteins | 2 | 2021 | 7370 | 0.03 | Why? |
| Mice, Knockout | 1 | 2017 | 1815 | 0.03 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.03 | Why? |
| Purines | 1 | 2017 | 816 | 0.03 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.03 | Why? |
| Immune Evasion | 1 | 2021 | 2081 | 0.03 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.03 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Peptides | 1 | 2021 | 2513 | 0.02 | Why? |
| Neutralization Tests | 1 | 2021 | 6698 | 0.02 | Why? |
| Workplace | 1 | 2019 | 2075 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.02 | Why? |
| HEK293 Cells | 1 | 2018 | 8394 | 0.02 | Why? |
| Protein Domains | 1 | 2018 | 6563 | 0.02 | Why? |
| Protease Inhibitors | 1 | 2021 | 3630 | 0.02 | Why? |
| Vero Cells | 1 | 2021 | 14117 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2021 | 7330 | 0.01 | Why? |
| Pandemics | 2 | 2021 | 389249 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.01 | Why? |
| Female | 2 | 2019 | 380317 | 0.01 | Why? |
| Male | 1 | 2017 | 367725 | 0.00 | Why? |
Amaro's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(180)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(74)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_